Pancreas regeneration: pancreatic progenitors and their niche

Meritxell Rovira Clusellas

POSTDOCTORAL RESEARCHERS
Joan Casamitjana i Vicente
PREDOCTORAL RESEARCHERS
Ángel Fernández Ruiz

Adrian Holguin Horcajo

SCIENTIFIC SUPPORT
  • Joel Moro Borrego
Regenerative Medicine
Regenerative Medicine

Scientific production

3

PAPERS

Average IF: 12,66

2

LED PAPERS

Average IF: 13,44

2 PUBLICATION IN FIRST DECILE

2 PUBLICATIONS IN FIRST QUARTILE

2 PUBLICATIONS IN OPEN ACCESS

Selected publications

  • Fernández,A;Casamitjana,J;Holguín Horcajo,A;Coolens,K;Mularoni,L;Guo,L;Hartwig,O et al, A Single-Cell Atlas of the Murine Pancreatic Ductal Tree Identifies Novel Cell Populations With Potential Implications in Pancreas Regeneration and Exocrine Pathogenesis, Gastroenterology, 2024;167(5):doi:10.1053/j.gastro.2024.06.008
  • Ramos Rodríguez,M;Subírana Granés,M;Norris,R;Sordi,V;Fernández,A;Fuentes Páez,G;Pérez González,B et al, Implications of noncoding regulatory functions in the development of insulinomas, Cell Genom, 2024;4(8):100604-100604, doi:10.1016/j.xgen.2024.100604
  • Holguín Horcajo,A;Sancho,R;Rovira,M, ß-Cell Regeneration Is Driven by Pancreatic Plasticity., Adv Anat Embryol Cell Biol, 2024;23991-115, doi:10.1007/978-3-031-62232-8_4

Research highlights

PROJECTS

3 ongoing competitive projects

NETWORKS

ASEICA
EASD
CIBER-BBN
SCB

Selected projects

  • excellence2023_34. THE CELL OF ORIGIN OF PANCREATIC CANCER: NOVEL OPPORTUNITIES FOR THE EARLY DIAGNOSIS AND TREATMENT. FUNDACIÓN CRIS DE INVESTIGACIÓN PARA VENCER EL CÁNCER CRIS CONTRA EL CÁNCER. Budget: 1.231.423,1€. 2024-2029. PI: Rovira Clusellas, Meritxell.
  • 96122. Comprehensive characterization of human ductal epithelium to identify endogenous progenitors as beta cell source. EUROPEAN FOUNDATION FOR THE STUDY OF DIABETES (EFSD). Budget: 50.448€. 2022-2024. PI: Rovira Clusellas, Meritxell/Eduard Montanya Mias.
  • HR23-00442. The cell of origin of Pancreatic Cancer: novel opportunities for the early diagnosis and treatment (oriPDAC4diagTreat). FUNDACIÓ “LA CAIXA”. Budget: 323.980€. 2023-2026. PI: Rovira Clusellas, Meritxell.
  • REGENERATIVE THERAPIES FOR DIABETES: DUCTAL NETWORK CHARACTERIZATION TO IDENTIFY NOVEL β CELL SOURCES: RegDuctProBeta. Bonpreu esclat. Budget: 25.907€. 2025- . PI: Rovira Clusellas, Meritxell.